These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy. Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260 [TBL] [Abstract][Full Text] [Related]
23. In Vivo Viscoelastic Response (VisR) Ultrasound for Characterizing Mechanical Anisotropy in Lower-Limb Skeletal Muscles of Boys with and without Duchenne Muscular Dystrophy. Moore CJ; Caughey MC; Meyer DO; Emmett R; Jacobs C; Chopra M; Howard JF; Gallippi CM Ultrasound Med Biol; 2018 Dec; 44(12):2519-2530. PubMed ID: 30174231 [TBL] [Abstract][Full Text] [Related]
24. Performance of Passive Muscle Stiffness in Diagnosis and Assessment of Disease Progression in Duchenne Muscular Dystrophy. Yu HK; Liu X; Pan M; Chen JW; Liu C; Wu Y; Li ZB; Wang HY Ultrasound Med Biol; 2022 Mar; 48(3):414-421. PubMed ID: 34893358 [TBL] [Abstract][Full Text] [Related]
25. T₂ mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy. Arpan I; Forbes SC; Lott DJ; Senesac CR; Daniels MJ; Triplett WT; Deol JK; Sweeney HL; Walter GA; Vandenborne K NMR Biomed; 2013 Mar; 26(3):320-8. PubMed ID: 23044995 [TBL] [Abstract][Full Text] [Related]
26. Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys. Heutinck L; Kampen NV; Jansen M; Groot IJ J Child Neurol; 2017 Apr; 32(5):450-457. PubMed ID: 28112012 [TBL] [Abstract][Full Text] [Related]
27. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series. Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189 [TBL] [Abstract][Full Text] [Related]
28. Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial. Mok E; Letellier G; Cuisset JM; Denjean A; Gottrand F; Alberti C; Hankard R PLoS One; 2009; 4(5):e5448. PubMed ID: 19421321 [TBL] [Abstract][Full Text] [Related]
29. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study. Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071 [TBL] [Abstract][Full Text] [Related]
31. Quantitative Skeletal Muscle MRI: Part 1, Derived T2 Fat Map in Differentiation Between Boys With Duchenne Muscular Dystrophy and Healthy Boys. Johnston JH; Kim HK; Merrow AC; Laor T; Serai S; Horn PS; Kim DH; Wong BL AJR Am J Roentgenol; 2015 Aug; 205(2):W207-15. PubMed ID: 26204309 [TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy. Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156 [TBL] [Abstract][Full Text] [Related]
33. A Longitudinal Study of Quantitative Muscle Strength and Functional Motor Ability in Ambulatory Boys with Duchenne Muscular Dystrophy. Buckon CE; Sienko SE; Fowler EG; Bagley AM; Staudt LA; Sison-Williamson M; Heberer KR; McDonald CM; Sussman MD J Neuromuscul Dis; 2022; 9(2):321-334. PubMed ID: 34924398 [TBL] [Abstract][Full Text] [Related]
34. Longitudinal changes in energy cost during walking in boys with Duchenne Muscular Dystrophy (DMD). Sienko S; Buckon CE; Bagley A; Staudt L; Fowler E; Heberer K; Sison-Williamson M; McDonald C; Sussman MD Gait Posture; 2021 Oct; 90():301-306. PubMed ID: 34564002 [TBL] [Abstract][Full Text] [Related]
35. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial. Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977 [TBL] [Abstract][Full Text] [Related]
36. Progression of muscular co-activation and gait variability in children with Duchenne muscular dystrophy: A 2-year follow-up study. Rinaldi M; Petrarca M; Romano A; Vasco G; D'Anna C; Bibbo D; Schmid M; Castelli E; Conforto S Clin Biomech (Bristol, Avon); 2020 Aug; 78():105101. PubMed ID: 32652381 [TBL] [Abstract][Full Text] [Related]